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Abstract
BACKGROUND: Prostate cancer is the second most common malignancy in men and has become the sixth leading 
cause of death in males worldwide. Eurycoma longifolia Jack root has active compounds, namely, quassinoids, 
eurycomanone, and canthine, which have potential as detoxicants, free radical antioxidants, and anticancer.
AIM: This study aimed to analyze the potential of the active compounds in E. longifolia Jack root in induce apoptosis 
in the prostate adenocarcinoma PC-3 cells.
METHODS: E. longifolia root active compounds were obtained by extracting them using ethanol solvent. The culture 
of prostate cancer PC-3 cell line was obtained from androgen-independent prostate adenocarcinoma with bone 
metastasis use as subject. Examination of the potency of E. longifolia root extract was conducted by observing the 
cells undergoing apoptosis with TUNEL assay.
RESULTS: One-way ANOVA test showed that the increase in apoptotic cells was associated proportionally with the 
concentration levels of E. longifolia root extract and showed a significant difference (α < 0.05). 
CONCLUSION: The higher the dose of E. longifolia root extract, the higher will be the apoptotic level of 
adenocarcinoma cells PC3. E. longifolia extract is potentially used in the treatment of prostate cancer by inducing 
apoptotic mechanisms.
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Background
Prostate cancer is the second most frequent 
cancer diagnosis made in men and the fifth leading 
cause of death worldwide. Prostate cancer may be 
asymptomatic at the early stage and often has an indolent 
course that may require only active surveillance. Based 
on GLOBOCAN 2018 estimates, 1,276,106 new cases 
of prostate cancer were reported worldwide and causing 
358,989 deaths (3.8% of all deaths caused by cancer in 
men) in 2018, with higher prevalence in the developed 
countries [1], [2]. Based on the 2011 Indonesian Society 
of Urologic Oncology (ISUO) data during 2006–2010, 
there were 971 prostate cancer patients. The average 
age was 68.3 years old, most were between 70 and 79 
years (37.6%). The most common stage was Stage 4 
(490 patients, 50.5%) [3].
Eurycoma longifolia Jack is a tropical plant 
from Simaroubaceae family distributed in Southeast 
Asia [4]. The root of E. longifolia Jack has several 
active compounds. E. longifolia Jack has been used as 
detoxicants, free radical antioxidants, and anticancer [5], 
[6]. Compounds in E. longifolia Jack are quassinoids [7], 
[8], [9]), alkaloid 9-methoxycanthine-6-one [10], [11], and 
alkaloid canthinone [12]. Quassinoids have cytostatic 
effect on colon cancer, breast cancer, pulmonary cancer, 
skin cancer (melanoma), and fibrosarcoma [13].
The objective of this study was to analyze the 
potency of active compounds of E. longifolia Jack root 
in induced apoptosis in prostate adenocarcinoma PC-3 
cells by TUNEL assay.
Methods
This study was experimental in vitro with post-
test control group design. The subject of this study is 
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prostate cancer PC-3 cell line which was obtained from 
androgen-independent prostate adenocarcinoma with 
bone metastasis.
Species identification of E. longifolia Jack
E. longifolia Jack roots were obtained from Great 
Jungle Park of Sultan Adam, Mandiangin Village, Banjar 
Regency, South Kalimantan. Morphological identification 
to determine E. longifolia Jack species was conducted 
in the UPT Plant Conservation Center, LIPI, Purwodadi.
E. longifolia Jack root extract
E. longifolia Jack roots were sliced thinly and 
then dried indirectly under the sun or aerated completely 
if there is no difference in weight during weighing. After 
they were dried, E. longifolia Jack roots were pulverized 
with blender and then weighed with analytical balance, 
until 100 g of powder was obtained. E. longifolia Jack 
root powder was wrapped in filter paper, and then, it was 
immersed with ethanol in the tubes until all powders in 
the filter paper were immersed in ethanol solvent for 
around 1 week. The result was evaporated using rotary 
evaporator and nitrogen gas to separate E. longifolia 
Jack roots from the ethanol solvent.
PC-3 cell line culture
The culture of prostate cancer PC-3 cell line 
was obtained from androgen-independent prostate 
adenocarcinoma with bone metastasis (PC-3 cell line 
ATCCR CRL-1435TM). The basic medium used was the 
Eagle’s Minimum Essential Medium (MEM). Complete 
growth medium was made by adding fetal bovine serum 
10% and 2 mM L-glutamine into the basic medium.
The prostate cancer PC-3 cells were washed 
with saline buffer, and the suspension was poured 
through 100 mm mesh. The cells were cultured in MEM 
prepared for fetal bovine serum growth. The culture was 
incubated in atmospheric humidity at 37°C with 95% air 
and 5% CO2. The cells were left adherent for <1 week, 
while kept changing the medium every 2–3 days. Cell 
harvest was conducted after 80% cells were confluent. 
The cells were washed twice with phosphate buffer 
saline (PBS), and trypsin-ethylenediaminetetraacetic 
acid (EDTA) was added. The cells were incubated in 
the incubator for 3 min. A 5 mL complete Roswell Park 
Memorial Institute (RPMI) was added to inactivate 
trypsin. Cell resuspension was conducted with pipette 
until each cell was separated. Separated cells were 
transferred into new sterile conical tubes.
Assessment of apoptosis of prostate 
adenocarcinoma PC-3 cells using the TUNEL assay
Cells were seeded at 6 × 10 cells/well in 24-well 
culture plate. The cells are exposed to E. longifolia 
Jack extract with various doses (100, 50, 25, 12.5, and 
6.25 µg/ml) and time (24 h and 48 h) and stored again in 
5% CO2 incubators, 37°C. After the incubation process 
is complete, the plate is removed from the incubator, 
the media are removed carefully, and the staining 
process of tunnel apoptosis is performed. Apoptotic cell 
was observed in prostate cancer cell samples with the 
terminal deoxynucleotidyl transferase-mediated dUTP 
biotin nick end labeling (TUNEL) method using in situ 
cell detection kit from the manufacturer. Cultured cells 
were washed three times with PBS at pH 7.4, then 
cells were incubated with 20 µg/mL proteinase-K for 
15 minutes at 37°C. After that, the cells were washed 
3 times with PBS at pH 7.4 for 5 min each, and then, 
they were incubated with 3% H2O2 for 15 min. The cells 
were washed 3 times with PBS at pH 7.4 for 5 min each; 
then, they were incubated with TUNEL fragmented DNA 
labeling for 60 min at 37°C. The cells were washed 
3 times with PBS at pH 7.4 for 5 min each, and then, they 
were incubated with diaminobenzidine (DAB) substrate 
for 40 min at 37°C. The cells were washed 3 times with 
PBS at pH 7.4 for 5 min each, and then, the cells were 
counterstained with Mayer’s hematoxylin, incubated 
for 10 min, and washed with tap water. The cells were 
rinsed with dH20 and air-dried. Mounting was conducted 
with Entellan and covered with the cover glass. Samples 
were examined with a light microscope. Apoptotic index 
was counted and stated as a percentage by dividing the 
TUNEL-positive cell count with the total prostate cancer 
cells (300–500). Positive immunostaining was evaluated 
randomly for three visual fields, and the average was 
counted with ImageJ program.
Results
The percentages of apoptotic adenocarcinoma 
cells after the administration of E. longifolia Jack root 
extract in various concentrations for 24 h are shown in 
Table 1.
Table 1: Percentage of apoptotic adenocarcinoma cells 
assessed with TUNEL assay, 24 hours after the administration 
of E. longifolia Jack root extract
Treatment Apoptotic cells (%)
1 2 3 4 5 Mean ± SD
Control 12.63 14.55 12.19 15.86 15.35 14.1 ± 1.63
6.25 µg/ml 18.36 20.20 16.67 14.6 11.76 16.3 ± 3.28
12.5 µg/ml 14.19 17.42 27.73 16.18 26.07 20.3 ± 6.15
25 µg/ml 23.12 17.01 27.85 18.90 28.27 23.0 ± 5.10
50 µg/ml 23.30 24.63 23.39 19.31 29.97 24.1 ± 3.83
100 µg/ml 54.18 47.99 33.64 20.90 40.15 39.4 ± 12.93
The percentage of apoptotic adenocarcinoma 
cells was analyzed with ANOVA test after the data 
normality and homogeneity assumption tests were 
conducted. The normality assumption was tested with 
Kolmogorov–Smirnov test, while the homogeneity test 
was conducted with Levene test. Data normality and 
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homogeneity assumptions are fulfilled when p-value is 
the same or higher than α (0.05). p-values for apoptosis 
variable are 0.098 and 0.135, more than α (p > 0.05). 
It means that the data normality and homogeneity 
assumptions have been fulfilled, and the hypothesis 
testing can be continued with one-way ANOVA.
The effect of E. longifolia Jack root extract 
administration at several concentrations on apoptosis 
in adenocarcinoma cells after 24 h was analyzed with 
ANOVA and then continued with Tukey HSD.
Based on the analysis results in Table 2, p-value 
is 0.000, which is lower than 0.05. It can be concluded 
that there was a significant difference between 
E. longifolia Jack root extract at various concentrations 
in the apoptosis of adenocarcinoma cells.
Table 2: The comparison of apoptotic adenocarcinoma 
cells using ANOVA and Tukey HSD tests 24 hours after the 
administration of E. longifolia Jack root extract
Treatment Mean ± SD p-value
Control 14.1 ± 1.63 0.000
6.25 µg/mL 16.3 ± 3.28
12.5 µg/mL 20.3 ± 6.15
25 µg/mL 23.0 ± 5.10
50 µg/mL 24.1 ± 3.83
100 µg/mL 39.4 ± 12.93
Tukey HSD test results in Table 2 showed that 
the group given E. longifolia Jack root extract at the 
concentration of 100 µg/mL had the highest average of 
apoptosis, while the control group showed the lowest 
average of apoptosis.
The percentages of apoptotic adenocarcinoma 
cells after the administration of E. longifolia Jack root 
extract in various concentrations for 48 h are shown in 
Table 3. The effect of E. longifolia Jack root ethanol extract 
administration at several concentrations on apoptosis 
in adenocarcinoma cells after 48 h was analyzed with 
ANOVA and then continued with Tukey HSD.
Table 3: Percentage of apoptotic adenocarcinoma cells 
assessed with TUNEL assay, 48 h after the administration of 
E. longifolia Jack root extract
Treatment Apoptotic cells (%)
1 2 3 4 5 Mean ± SD
Control 18.41 22.63 16.78 16.73 27.97 20.5 ± 4.82
6.25 µg/ml 16.27 26.73 23.12 25.16 25.17 23.2 ± 4.06
12.5 µg/ml 25.65 31.58 29.50 24.05 28.18 27.8 ± 3.00
25 µg/ml 36.7 44.45 17.72 26.05 28.13 30.6 ± 10.27
50 µg/ml 31.87 33.15 40.08 24.62 28.36 31.6 ± 5.78
100 µg/ml 46.72 41.52 45.74 52.87 30.76 43.5 ± 8.21
p-values for apoptosis variable are 0.086 
and 0.161, more than α (p > 0.05). It means that data 
normality and homogeneity assumptions have been 
fulfilled, and the hypothesis testing can be continued 
with one-way ANOVA.
Based on the analysis results in Table 4, 
p-value is 0.000, which is lower than 0.05. It can be 
concluded that there was a significant difference 
between E. longifolia Jack root extract at various 
concentrations in the apoptotic adenocarcinoma cells.
Tukey HSD test results in Table 4 showed that 
the group given E. longifolia Jack root extract at the 
concentration of 100 µg/mL had the highest average of 
apoptosis, while the control group showed the lowest 
average of apoptosis.
Table 4: The comparison of apoptotic adenocarcinoma 
cells using ANOVA and Tukey HSD tests after 48 h after the 
administration of E. longifolia Jack root extract
Treatment Mean ± SD p-value
Control 20.5 ± 4.82 0.000
6.25 µg/mL 23.2 ± 4.06
12.5 µg/mL 27.8 ± 3.00
25 µg/mL 30.6 ± 10.27
50 µg/mL 31.6 ± 5.78
100 µg/mL 43.5 ± 8.21
Based on apoptotic adenocarcinoma cell data, 
the values of IC50 for E. longifolia Jack root extract 
treatment after 24 and 48 h were counted. The values 
of IC50 are shown in Figure 1.
Figure 1: Values of IC50 for E. longifolia Jack extract after 24 
(7.99 μg/mL) and 48 (7.71 μg/mL) h.
The results of the TUNEL assay as a marker of 
adenocarcinoma apoptotic cells after 24 and 48 h are 
shown in Figures 2 and 3.
Figure 2: Apoptotic adenocarcinoma cells were characterized by 
brown color in the nucleus, shown by the TUNEL assay after 24 h. 
(A) Control, (B) adenocarcinoma cells given E. longifolia Jack root 
extract at the concentration of 6.25 µg/mL, (C) adenocarcinoma cells 
given E. longifolia Jack root extract at the concentration of 12.5 µg/mL, 
(D) adenocarcinoma cells given E. longifolia Jack root extract at the 
concentration of 25 µg/mL, (E) adenocarcinoma cells given E. longifolia 
Jack root extract at the concentration of 50 µg/mL, (F) adenocarcinoma 
cells given E. longifolia Jack root extract at the concentration of 100 µg/
mL. Apoptotic cell area was analyzed with ImageJ program.
a b
c d
e f
Figures 2 and 3 show apoptosis in 
adenocarcinoma cells after the administration of 
E. longifolia Jack root extract. Apoptotic cells were 
A - Basic Sciences Pharmacology
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characterized by dark brown nuclei, shown by arrows.
Figure 3: Apoptotic adenocarcinoma cells were characterized by 
brown color in the nucleus, shown by the TUNEL assay after 48 h. 
(A) Control, (B) adenocarcinoma cells given E. longifolia Jack root 
extract at the concentration of 6.25 µg/mL, (C) adenocarcinoma cells 
given E. longifolia Jack root extract at the concentration of 12.5 µg/mL, 
(D) adenocarcinoma cells given E. longifolia Jack root extract at the 
concentration of 25 µg/mL, (E) adenocarcinoma cells given E. longifolia 
Jack root extract at the concentration of 50 µg/mL, (F) adenocarcinoma 
cells given E. longifolia Jack root extract at the concentration of 100 µg/
mL. Apoptotic cell area was analyzed with ImageJ program.
a b
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e f
Figure 4 shows the comparison of the average 
percentage of apoptosis in adenocarcinoma cells. The 
highest average apoptotic cell percentage was given 
by the treatment with E. longifolia Jack root extract 
at the concentration of 100 µg/mL, with average 
percentages of 39.4% (24 h) and 43.5% (48 h). Based 
on the analysis, E. longifolia Jack root extract at the 
concentration of 100 µg/ml had the highest effect on the 
increase apoptotic cells.
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Figure 4: Comparison of the average percentage of apoptotic 
adenocarcinoma cells given E. longifolia Jack root extract at various 
concentrations after 24 and 48 h.
Discussion
E. longifolia Jack (known as Pasak Bumi) is 
one kind of endemic plant in South Borneo, Indonesia. 
It belongs to Simaroubaceae family and believes a 
function as an aphrodisiac [14]. The plant is reported to 
be rich in various classes of bioactive compounds such 
as quassinoids, canthin-6-one alkaloids, β-carboline 
alkaloids, triterpene tirucallane type, squalene derivatives 
and biphenyl neolignan, eurycolactone, laurycolactone, 
and eurycomalactone, and bioactive steroids. Among 
these phytoconstituents, quassinoids account for a 
major portion of E. longifolia root phytochemicals [15]. 
Furthermore, E. longifolia Jack root known to consist of 
an essential active compound, such as eurycomanone, 
quassinoids, and canthine, which have anticancer effect 
[16]. Hajjouli et al. concluded that E. longifolia constituents, 
eurycomanone and eurycomanol, are the regulators of 
signaling pathways involved in proliferation, cell death, 
and inflammation [17]. The antitumor activity is one of 
the most impressive medicinal properties of quassinoids 
and has been well researched [18,19]. Many quassinoids 
display antitumor activity in different potencies [20].
In silico study by Rahman et al showed that 
only eurycomanone and quassinoids had Pa > Pi for 
antineoplastic agonist, and the value was between 0.8 
and 1 for apoptosis [21]. The analysis will be resulting 
probability of active (Pa) and the probability of inactive 
(Pi) score with a range from 0 to 1. If Pa > Pi mean, 
it is potential for a specific therapeutic candidate [22]. 
Canthine showed a lower value. Based on the prediction 
as anticancer, active compounds, eurycomanone and 
quassinoids, have potency as therapeutic agents due 
to their ability as apoptotic agents and proliferation 
inhibitors by inhibiting active site of RAS protein [21].
Apoptosis is arguably one of the most potent 
forms of defense against cancer [23]. In cancer therapy, 
one approach that suppresses the tumor growth is by 
activating the apoptotic machinery in the cell due to the 
effect of anticancer agents. Therefore, the induction of 
apoptosis has been recognized as a strategy for the 
identification of anticancer drugs [24]. Apoptotic agents 
that suppress the proliferation of malignant cells by 
inducing apoptosis may represent a useful mechanistic 
approach to both, cancer chemoprevention and 
chemotherapy [25]. The phase of apoptotic execution 
involves the activation of several series caspases. 
Upstream caspase of the intrinsic pathway is caspase-9 
while the extrinsic pathway is caspase 8. The intrinsic 
and extrinsic pathways will converge to activate 
caspase-3 which plays a role in the apoptotic nuclear 
effector [26]. Direct activation of the execution caspase 
can be used in anticancer therapeutic strategies by 
increasing the concentration of procaspase-3 [27].
This study showed that E. longifolia Jack root 
extract increased the apoptotic level of PC3 cells. 
There was a proportional correlation, where the higher 
the dose of E. longifolia root extract, the higher the 
apoptotic level of adenocarcinoma cells. In addition, 
after 24 h of treatment with E. longifolia Jack extract, 
cells showed an increase in the percentage of DNA 
damaged cells of 39.4% at highest concentration 
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(100 μg/ml) and 43.5%, after 48 h of incubation. This 
confirms that E. longifolia Jack extract induces early 
signs of apoptosis after 24 h, but cell death takes 
longer. This strongly correlates to the study performed 
by Nurkhasanah et al. after exposure of HeLa cells with 
eurycomanone, the percentage of apoptotic cells in the 
annexin +/PI- quadrant increased from 24 to 48 h of 
exposure, thus indicating that eurycomanone induced 
apoptosis in HeLa cells [28]. Furthermore, it was found 
that treatment with E. longifolia Jack extract induced 
DNA fragmentation by TUNEL assay in PC3 cells as 
well, in a time- and concentration-dependent manner.
Conclusion
There is a clear effect of E. longifolia root extract 
administration on the increase in apoptotic prostate 
adenocarcinoma cells. E. longifolia active ingredients 
are potentially used in the treatment of prostate cancer 
by inducing apoptotic mechanisms.
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